La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Integrated Research Croissance future

Future contrôle des critères 0/6

Les bénéfices de Integrated Research devraient diminuer de 20.4% par an tandis que son chiffre d'affaires annuel devrait croître de 0.4% par an. Le BPA devrait croître de diminuer de 21.7% par an. Le rendement des capitaux propres devrait être 12.3% dans 3 ans.

Informations clés

-20.4%

Taux de croissance des bénéfices

-21.7%

Taux de croissance du BPA

Software croissance des bénéfices	27.4%
Taux de croissance des recettes	0.4%
Rendement futur des capitaux propres	12.3%
Couverture par les analystes	Low
Dernière mise à jour	20 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Impressive Earnings May Not Tell The Whole Story For Integrated Research (ASX:IRI)

Aug 29

Investors Don't See Light At End Of Integrated Research Limited's (ASX:IRI) Tunnel And Push Stock Down 37%

Aug 21

Integrated Research Limited (ASX:IRI) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Jun 28

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

Jun 11

Why Investors Shouldn't Be Surprised By Integrated Research Limited's (ASX:IRI) Low P/S

Apr 20

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

Mar 02

Investors Could Be Concerned With Integrated Research's (ASX:IRI) Returns On Capital

Apr 05

Investors Could Be Concerned With Integrated Research's (ASX:IRI) Returns On Capital

Sep 27

Does Integrated Research (ASX:IRI) Have A Healthy Balance Sheet?

Aug 22

Integrated Research (ASX:IRI) Will Will Want To Turn Around Its Return Trends

Jun 14

Integrated Research (ASX:IRI) Seems To Use Debt Quite Sensibly

May 03

We're Watching These Trends At Integrated Research (ASX:IRI)

Mar 08

If You Had Bought Integrated Research's (ASX:IRI) Shares Three Years Ago You Would Be Down 34%

Feb 15

Should You Buy Integrated Research Limited (ASX:IRI) For Its Dividend?

Jan 28

Is There More To The Story Than Integrated Research's (ASX:IRI) Earnings Growth?

Jan 10

Need To Know: This Analyst Just Made A Substantial Cut To Their Integrated Research Limited (ASX:IRI) Estimates

Dec 22

Integrated Research Limited's (ASX:IRI) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 14

Prévisions de croissance des bénéfices et des revenus

ASX:IRI - Estimations futures des analystes et données financières antérieures (AUD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
6/30/2027	84	15	N/A	14	1
6/30/2026	82	15	N/A	13	1
6/30/2025	81	16	N/A	12	1
6/30/2024	83	27	13	13	N/A
3/31/2024	78	3	13	15	N/A
12/31/2023	72	-21	13	16	N/A
9/30/2023	71	-25	10	15	N/A
6/30/2023	70	-29	6	14	N/A
3/31/2023	69	-13	2	12	N/A
12/31/2022	69	3	-1	9	N/A
9/30/2022	66	2	2	13	N/A
6/30/2022	63	2	5	17	N/A
3/31/2022	70	6	6	18	N/A
12/31/2021	77	10	7	18	N/A
9/30/2021	78	9	8	20	N/A
6/30/2021	78	8	9	21	N/A
3/31/2021	85	10	9	22	N/A
12/31/2020	92	12	9	22	N/A
9/30/2020	101	18	9	23	N/A
6/30/2020	111	24	9	24	N/A
3/31/2020	107	23	10	25	N/A
12/31/2019	104	22	11	25	N/A
9/30/2019	102	22	10	23	N/A
6/30/2019	101	22	9	21	N/A
3/31/2019	98	22	10	22	N/A
12/31/2018	96	22	10	23	N/A
9/30/2018	93	20	10	22	N/A
6/30/2018	91	19	9	21	N/A
3/31/2018	92	20	N/A	22	N/A
12/31/2017	94	20	N/A	23	N/A
9/30/2017	92	19	N/A	25	N/A
6/30/2017	91	19	N/A	26	N/A
3/31/2017	90	18	N/A	24	N/A
12/31/2016	88	18	N/A	22	N/A
9/30/2016	87	17	N/A	19	N/A
6/30/2016	85	16	N/A	16	N/A
3/31/2016	80	14	N/A	16	N/A
12/31/2015	76	13	N/A	17	N/A
9/30/2015	73	14	N/A	19	N/A
6/30/2015	70	14	N/A	21	N/A
3/31/2015	65	13	N/A	19	N/A
12/31/2014	61	12	N/A	16	N/A
9/30/2014	57	10	N/A	16	N/A
6/30/2014	53	8	N/A	16	N/A
3/31/2014	53	10	N/A	18	N/A
12/31/2013	54	11	N/A	21	N/A
9/30/2013	51	10	N/A	19	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Les bénéfices de IRI devraient diminuer au cours des 3 prochaines années ( -20.4% par an).

Bénéfices vs marché: Les bénéfices de IRI devraient diminuer au cours des 3 prochaines années ( -20.4% par an).

Croissance élevée des bénéfices: Les bénéfices de IRI devraient baisser au cours des trois prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de IRI ( 0.4% par an) devrait croître plus lentement que le marché de Australian ( 5.4% par an).

Croissance élevée des revenus: Le chiffre d'affaires de IRI ( 0.4% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de IRI devrait être faible dans 3 ans ( 12.3 %).

Integrated Research Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Integrated Research Limited Provides Revenue Guidance for the Full Year 2023

Consensus EPS estimates fall by 22%

Price target increased by 18% to AU$0.65

Price target increased to AU$0.55

Consensus EPS estimates fall by 75%

Price target decreased to AU$1.00

Recent updates

Impressive Earnings May Not Tell The Whole Story For Integrated Research (ASX:IRI)

Upcoming dividend of AU$0.02 per share

Integrated Research Limited Declares Fully Franked Final Dividend for the Year Ended June 30, 2024, Payable on October 15, 2024

Investors Don't See Light At End Of Integrated Research Limited's (ASX:IRI) Tunnel And Push Stock Down 37%

Integrated Research Limited, Annual General Meeting, Nov 27, 2024

New major risk - Revenue and earnings growth

Integrated Research Limited Announces the Appointment of Ian Lowe as the New Chief Executive Officer, Effective October 1, 2024

Now 22% overvalued after recent price rise

Integrated Research Limited to Report Fiscal Year 2024 Results on Aug 20, 2024

Now 26% overvalued after recent price rise

Now 22% overvalued after recent price rise

Integrated Research Limited (ASX:IRI) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Now 20% overvalued after recent price rise

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

Why Investors Shouldn't Be Surprised By Integrated Research Limited's (ASX:IRI) Low P/S

Independent Non-Executive Director recently bought AU$98k worth of stock

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

First half 2024 earnings released: EPS: AU$0.064 (vs AU$0.019 in 1H 2023)

Integrated Research Limited to Report First Half, 2024 Results on Feb 22, 2024

Integrated Research Limited Announces Resignation of James Scott as Director, Effective 30 January 2024

Integrated Research Limited Announces Chief Financial Officer Changes

Integrated Research Limited Provides Revenue Guidance for the Full Year 2023

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Integrated Research Limited Announces the Appointment of Michael Hitz as Independent Non-Executive Director

Integrated Research Limited Announces Resignation of Allan Brackin as Director, Effective from 30 September 2023

Is Integrated Research Limited (ASX:IRI) Potentially Undervalued?

Full year 2023 earnings: EPS misses analyst expectations

Integrated Research Limited, Annual General Meeting, Nov 22, 2023

New minor risk - Financial data availability

Consensus EPS estimates fall by 22%

Integrated Research Limited to Report Fiscal Year 2023 Results on Aug 25, 2023

What Is Integrated Research Limited's (ASX:IRI) Share Price Doing?

First half 2023 earnings released: EPS: AU$0.019 (vs AU$0.01 in 1H 2022)

Price target increased by 18% to AU$0.65

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Price target increased to AU$0.55

Integrated Research Announces David Purdue to Retire as Company Secretary, Effective 30 September 2022

Now 23% undervalued after recent price drop

Integrated Research Limited, Annual General Meeting, Nov 23, 2022

Full year 2022 earnings released: EPS: AU$0.009 (vs AU$0.046 in FY 2021)

Now 22% undervalued after recent price drop

IR Appoints Rodney Foreman as Senior Vice President, Americas

Integrated Research Announces Executive Changes

Is Integrated Research Limited (ASX:IRI) Potentially Undervalued?

Integrated Research Limited to Report Fiscal Year 2022 Results on Aug 18, 2022

Integrated Research Limited Appoints Katrina Small as Chief People Officer

Now 23% undervalued after recent price drop

Integrated Research Limited Announces the Resignation of Peter Adams as Chief Financial Officer, Effective 31 August 2022

Consensus EPS estimates fall by 75%

Is Integrated Research (ASX:IRI) Using Too Much Debt?

Price target decreased to AU$1.00

Integrated Research Appoints William Witherow as a Company Secretary

Integrated Research Limited Announces Director Appointment

IR's Real-Time Payments Product to Power Organizations' Financial and Business Efficiencies

Investors Could Be Concerned With Integrated Research's (ASX:IRI) Returns On Capital

IR Appoints Stuart Matthewman as Chief Marketing Officer

First half 2022 earnings: EPS exceeds analyst expectations

Consensus EPS estimates fall by 11%

IR Launches Remote Monitoring and Management Solution for Collaboration Spaces

IR Achieves Service Organization Control (SOC) 2 Type I Certification, Affirming its Strong Security Practices and Commitment to Safeguarding Customers and Partners

Price target decreased to AU$1.50

Non-Executive Independent Director recently bought AU$80k worth of stock

Investors Could Be Concerned With Integrated Research's (ASX:IRI) Returns On Capital

Does Integrated Research (ASX:IRI) Have A Healthy Balance Sheet?

Full year 2021 earnings released: EPS AU$0.046 (vs AU$0.14 in FY 2020)

Consensus forecasts updated

Investor sentiment improved over the past week